The Importance of Supplier Quality for MedTech

by | May 5, 2021 | Blog, FDA, Medical Devices, MedTech, Quality, Supplier Management

It is common knowledge that supplier quality is a critical piece of any MedTech QMS. No matter which regulatory requirements apply to you, or which ISO standards you comply with, supplier quality plays a fundamental role in ensuring your product is safe and effective. Although design and manufacturing controls are often thought of as the “make or break” processes, if your organization does not have robust supplier quality controls it could have disastrous outcomes.

Arguable one of the largest facets of supplier quality within the MedTech industry is contract manufacturing. Contract manufacturing is essentially outsourcing all or part of your manufacturing processes to a supplier when you do not have the internal resources to complete it. Contract manufacturing is a budding sub-industry that is expected to grow at a compounded annual rate of roughly 11%, from 2020 through 2027.1 With this type of growth, organizations can expect to see the FDA and other regulatory agencies prioritize how these suppliers are managed.

Contract manufacturing is a process that has inherit risk. It is important that you select a contract manufacturer that has a robust QMS, understands the regulatory requirements they are responsible for, and is willing to work with you to accomplish overall regulatory compliance. A large part of supplier quality is how you qualify suppliers, and contract manufacturers should go through the highest level of scrutiny.

Qualifying any supplier should begin with a full understanding of the risk they present to your product/overall compliance status. A contract manufacturer has one of the highest risks since they have the most direct impact on product quality. Other types of suppliers who provide lower risk commodities/services may not require the same level of controls. Part of the controls that should be employed, especially for higher risk suppliers, include audits and enforcing quality agreements.

Supplier quality should be one of your most robust QMS processes, no matter what your product is. If you need assistance keeping up with supplier audits, or improving your overall supplier quality process, EMMA International can help! Give us a call at 248-987-4497 or email info@emmainternational.com to learn more.


1Precedence Research (Oct 2020) Medical Device Contract Manufacturing Market Size retrieved on 05/04/2021 from: https://www.globenewswire.com/news-release/2020/10/15/2109290/0/en/Medical-Device-Contract-Manufacturing-Market-Size-to-Hit-US-97-52-Bn-by-2027.html#:~:text=According%20to%20Precedence%20Research%2C%20the,97.52%20billion%20by%202027%20globally.&text=Contra

Madison Green

Madison Green

Director of Technical Operations - Mrs. Green serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Mrs. Green also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Mrs. Green holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

EU MDR: Extending the Transition Period for Medical Devices

EU MDR: Extending the Transition Period for Medical Devices

The European Commission has implemented a proposal to extend the transitional period to certify medical devices under the Medical Devices Regulation (MDR). The proposal allows more time for manufacturers to transition from the previously applicable rules to the new requirements of the Regulation
The End of the COVID-19 Public Health Emergency

The End of the COVID-19 Public Health Emergency

After over 3 years, the COVID-19 Public Health Emergency (PHE) will end on May 11, 2023, the Biden Administration announced last week.1After 3.5 years of the modified policy to allow for amore efficient path for COVID-19-related medical products to get to market, this begs the question of how it will impact the MedTech world.
Process Validation

Process Validation

All right, you have just gotten all of your paperwork together, submitted the right forms to the right people, set up your factory, hired and trained your staff; now it’s time to make the medical devices. The regulatory nonsense is over and done, right?

Ready to learn more about working with us?

Pin It on Pinterest

Share This